Biologics Legislation In The 111th Congress
Two bills have been introduced in the House that aim to create an FDA approval process for follow-on biologics similar to that established for generic drugs in the Hatch-Waxman Act of...To view the full article, register now.
Already a subscriber? Click here to view full article